p73, an important developmental gene, shares a high sequence homology with p53 and induces both G 1 cell cycle arrest and apoptosis. However, the molecular mechanisms through which p73 induces apoptosis are unclear. We found that p73-induced apoptosis is mediated by PUMA (p53 up-regulated modulator of apoptosis) induction, which, in turn, causes Bax mitochondrial translocation and cytochrome c release. Overexpression of p73 isoforms promotes cell death and bax promoter transactivation in a time-dependent manner. However, the kinetics of apoptosis do not correlate with the increase of Bax protein levels. Instead, p73-induced mitochondrial translocation of Bax is kinetically compatible with the induction of cell death. p73 is localized in the nucleus and remains nuclear during the induction of cell death, indicating that the effect of p73 on Bax translocation is indirect. The ability of p73 to directly transactivate PUMA and the direct effect of PUMA on Bax conformation and mitochondrial relocalization suggest a molecular link between p73 and the mitochondrial apoptotic pathway. Our data therefore indicate that PUMA-mediated Bax mitochondrial translocation, rather than its direct transactivation, correlates with cell death. Finally, human ⌬Np73, an isoform lacking the amino-terminal transactivation domain, inhibits TAp73-induced as well as p53-induced apoptosis. The ⌬Np73 isoforms seem therefore to act as dominant negatives, repressing the PUMA/Bax system and, thus, finely tuning p73-induced apoptosis. Our findings demonstrate that p73 elicits apoptosis via the mitochondrial pathway using PUMA and Bax as mediators.
p73, an important developmental gene, shares a high sequence homology with p53 and induces both G 1 cell cycle arrest and apoptosis. However, the molecular mechanisms through which p73 induces apoptosis are unclear. We found that p73-induced apoptosis is mediated by PUMA (p53 up-regulated modulator of apoptosis) induction, which, in turn, causes Bax mitochondrial translocation and cytochrome c release. Overexpression of p73 isoforms promotes cell death and bax promoter transactivation in a time-dependent manner. However, the kinetics of apoptosis do not correlate with the increase of Bax protein levels. Instead, p73-induced mitochondrial translocation of Bax is kinetically compatible with the induction of cell death. p73 is localized in the nucleus and remains nuclear during the induction of cell death, indicating that the effect of p73 on Bax translocation is indirect. The ability of p73 to directly transactivate PUMA and the direct effect of PUMA on Bax conformation and mitochondrial relocalization suggest a molecular link between p73 and the mitochondrial apoptotic pathway. Our data therefore indicate that PUMA-mediated Bax mitochondrial translocation, rather than its direct transactivation, correlates with cell death. Finally, human ⌬Np73, an isoform lacking the amino-terminal transactivation domain, inhibits TAp73-induced as well as p53-induced apoptosis. The ⌬Np73 isoforms seem therefore to act as dominant negatives, repressing the PUMA/Bax system and, thus, finely tuning p73-induced apoptosis. Our findings demonstrate that p73 elicits apoptosis via the mitochondrial pathway using PUMA and Bax as mediators.
p73 is a member of the p53 family (1) . The two proteins show a high degree of sequence homology, particularly in the central sequence-specific DNA binding domain, the amino-terminal activation domain, and the carboxyl-terminal oligomerization domain (1) .
Even though p73 shows an evident developmental role, the strong structural similarity suggests that, at least in part, the function of p73 may closely resemble that of p53 (2, 3) . Indeed, like p53, p73 induces G 1 cell growth arrest (1, 4) , activates the transcription of some endogenous p53 target genes such as p21Waf1/Cip1, RGC (ribosomal gene cluster), mdm2, bax, cyclin G, GADD45 (growth arrest-and DNA damage-inducible 45), IGF-BP3 (insulin-like growth factor-binding protein 3), and 14-3-3 (4 -8) , and induces apoptosis irrespective of p53 status (1, 4) . The structural integrity of the p73 DNA binding domain is required for these activities, suggesting that p73 recognizes the p53-responsive DNA elements.
The levels of p73 are not changed by exposure to DNAdamaging agents such as actinomycin D or UV irradiation, which increase p53 levels (1) Moreover, steady-state levels of p73 are not reduced by complex formation with Mdm2 (7, 8) , which targets p53 for ubiquitin-mediated proteolysis (9 -11) . Recent studies have shown that p73 can be stabilized and tyrosine phosphorylated by c-Abl following DNA damage, leading to an enhanced p73-mediated apoptotic response (12) (13) (14) . Therefore there are both similarities and differences in the mechanisms of p53-and p73-mediated apoptosis.
bax, a pro-apoptotic Bcl-2 family member, is a p53 and a p73 target gene (15, 16) . In unstressed cells, the Bax protein exists as an inactive monomer in the cytosol and is induced to homooligomerize and translocate to mitochondria upon death stimuli, thus leading to cytochrome c release and caspase activation (17) (18) (19) (20) . Cytochrome c release results from the induction of the mitochondrial permeability transition, an event associated with disruption of the mitochondrial inner transmembrane potential ⌬⌿m (21) that has been implicated in a variety of apoptotic phenomena (22, 23) . Unfortunately however, very little is known about the molecular events through which p73 induces apoptosis.
Here we report a study on p73-induced apoptosis in Saos-2 cells demonstrating that the ␥ isoform is the most effective both in the induction of apoptosis and in bax transactivation. However, at least in this model, bax transactivation does not seem to be crucial for the induction of death. We show that, in cells undergoing p73-dependent apoptosis, p73 displays a nuclear localization pattern, whereas Bax translocates from the cytosol to mitochondria, thus causing cytochrome c release. The BH3-only protein PUMA (p53 up-regulated modulator of apoptosis) is transcriptionally induced during p73-mediated cell death and favors a conformational change and relocalization of Bax to the mitochondria. Moreover, ⌬Np73, 1 a recently cloned p73 isoform (24) that lacks the transactivation domain and acts as a p73 dominant negative, inhibits p73-induced apoptosis. Here we provide evidence for a transcription-independent effect of p73 on Bax able to activate the mitochondrial pathway during cell death.
EXPERIMENTAL PROCEDURES
Cell Culture-Saos-2 and HeLa cells stably expressing Bax-GFP or the cytochrome c-GFP fusion protein were cultured in a 1:1 mixture of Ham's F-12/Dulbecco's minimal essential medium supplemented with 10% heat-inactivated fetal bovine serum at 37°C in a humidified atmosphere of 5% CO 2 in air. Saos-2 cells with doxycycline (dox)-inducible expression of p73 isoforms (25) or PUMA (prepared as in Ref. 25) were cultured in the same medium supplemented with 10% heat-inactivated, tetracycline-free fetal bovine serum (Tet system-approved fetal bovine serum, Clontech). Both p73 and PUMA inducible cell lines were HAtagged in order to monitor the steady-state levels of protein induction by Western and laser densitometry. Mouse embryo fibroblasts (MEFs) for null p53, Bax, Bak, Bax/Bak, and U2OS cells were grown in similar conditions. To induce protein expression, the tetracycline-inducible cell lines were treated with the tetracycline analog dox at 2.5 g/ml as indicated.
Plasmids-Human p73 isoforms (including ⌬84p73␤) and p53 cDNAs in pCDNA3 (18, 26) , ⌬Np73 (24),and PUMA cDNA (27, 28) have been described previously.
Western Blot Analysis-Saos-2 subclones with dox-inducible expression of p73 isoforms were treated with dox (2.5 g/ml) for 48 h and lysed in buffer A (50 mM Tris, pH 8, 150 mM NaCl, 0.5% Nonidet P-40, 0.5 mg/ml leupeptin, 1 mg/ml aprotinin, and 0.5 mM phenylmethylsulfonyl fluoride) for 1 h on ice. The lysate was cleared by centrifugation, and 20-g aliquots of cell extract, as determined by the Bradford method, were resolved by electrophoresis in a 12% SDS-polyacrylamide gel, transferred to a polyvinylidene difluoride membrane, and probed with anti-HA antibody (Santa Cruz Biotechnology, Inc., Santa Cruz, CA) to quantitate the steady-state levels of protein expression.
To analyze the expression of Bax in the mitochondrial fraction, cells were resuspended in 3 ml of ice-cold buffer B (250 mM sucrose, 20 mM HEPES, 10 mM KCl, 1.5 mM MgCl 2 , 1 mM EDTA, 1 mM EGTA, 1 mM dithiothreitol, 17 g/ml phenylmethylsulfonyl fluoride, 8 g/ml aprotinin, and 2 g/ml leupeptin, pH 7.4. Cells were passed through an ice-cold cylinder cell homogenizer (H&Y Enterprise, Redwood City, CA).
Intact cells and nuclei were pelleted for 10 min at 750 ϫ g. The supernatant was spun at 10,000 ϫ g for 20 min. The pellet was lysed in buffer A as reported above and represents the mitochondrial fraction. 20 g of this lysate was resolved by electrophoresis in a 12% SDSpolyacrylamide gel, transferred to a PVDF membrane, and probed with anti-Bax, an anti-procaspase antibody (Pharmingen), or an anti-Bax conformational epitope (antibody 6A7, donated by C. Thompson). Immunocomplexes were detected by a chemiluminescence-based system (Amersham Biosciences) according to the manufacturer's instructions. Densitometric analysis was carried out using Kodak one-dimensional 2.0 software.
Determination of Apoptosis-To estimate DNA fragmentation, Saos-2 cells with dox-inducible expression of p73 isoforms were treated with dox (2.5 g/ml) for 48 h, collected at 800 ϫ g for 10 min, and fixed with a 1:1 phosphate-buffered saline and methanol-acetone (4:1 (v/v)) solution at Ϫ20°C. Hypodiploid sub-G 1 events were evaluated by flow cytometry after propidium iodide (PI) staining, as described previously (13, 24, 26) . For each point 20,000 events were collected, excluding doublets and aggregates, by electronic gate.
Bax Staining-Saos-2 cells with inducible expression of p73␥ and p53 were stimulated to produce the protein for the indicated times using dox (2.5 g/ml) and then fixed in 4% paraformaldehyde in phosphate-buffered saline (pH 7.4) for 15 min. Cells were then permeabilized for 2 min in 0.1% Triton X-100 in phosphate-buffered saline and incubated for 1 h with anti-Bax antibody followed by 30 min of incubation with anti-rabbit ALEXA 488 antibody (Molecular Probes). 10,000 events were collected by monitoring 530-nm fluorescence on a FACSCalibur flow cytometer (BD Biosciences), as indicated above.
Subcellular Localization-Cells were grown overnight on a glass coverslip and, after the indicated treatments, fixed in 4% paraformaldehyde in phosphate-buffered saline (pH 7.4) for 15 min. Saos-2 p73␥-inducible cells were induced with dox (2.5 g/ml) for 24 h and then treated, when indicated, with 25 M cisplatin for 24 h. Immunofluorescence was carried out using an anti-HA or anti-Bax antibody combined with TUNEL reaction according to the manufacturer's instructions (in situ cell death detection kit, TMR red, Roche Applied Science). HeLa cells stably expressing Bax-GFP were cotransfected by using LipofectAMINE 2000 (Invitrogen) with p73␥ and pDS-Red1-Mito (3:1).
Confocal images were acquired by using a PCM-2000 confocal microscope (Nikon) and excited with a 488-nm argon-ion laser line or a 542-nm helium-neon laser detecting with the appropriate filter set (515/30 green filter and 595/70 red filter). Images were then processed by using PCM-2000 software (Nikon).
Luciferase Assay-Saos-2 cells with dox-inducible p73 isoforms or p53 were cotransfected with a reporter plasmid containing luciferase cDNA under the control of the bax promoter (Bax-Pr/Luc) and a Renilla plasmid as internal standard (40:1). p73 or p53 expression was then induced by treatment with dox (2.5 g/ml). Saos-2 cells were cotransfected with expression plasmids encoding p73␣ or p53 with or without ⌬Np73␣, ⌬Np73␤, or ⌬Np73␥, together with Bax-Pr/Luc (bax-Pr/Luc: p73/p53:⌬Np73:Renilla ϭ 1:1:8:0.25). N1E-115 cells were cotransfected with an expression plasmid encoding p73␣, p73␤, p73␥, p73␦, or p53, with or without ⌬84p73␤ together with Bax-Pr/Luc. Luciferase assays were carried out 48 h after transfection with the dual-luciferase assay system (Promega) according to the manufacturer's instructions. Luminescence was detected by using an EG&G Berthold Lumat LB 9507 luminometer, averaging the signal for 10s.
RESULTS AND DISCUSSION
p73 Expression Induces Apoptosis in Saos-2 Cells-To study the mechanisms through which p73 induces apoptosis, we took advantage of three Saos-2-derived cell lines stably transfected with the HA-tagged, dox-inducible TAp73 isoforms ␣, ␤, or ␥ (25). Saos-2 cells are p53-null and do not express p73 at either mRNA and protein levels, therefore forming a suitable model for evaluation of the induction of apoptosis by p73.
We measured p73 expression in Saos-2 cells incubated with the tetracycline analog dox (2.5 g/ml). Cells were collected at different time points and assayed for protein expression using the anti-HA antibody. p73 protein levels were undetectable in untreated cells, whereas the expression of all the three p73 isoforms was induced in a time-dependent manner following treatment with dox ( Fig 1A) . Densitometric analysis of p73 induction revealed that ␤ and ␥ isoforms were the most highly induced upon dox treatment (Fig. 1B) . To test whether caspases play a role during p73-induced cell death, we measured the proenzyme expression levels of caspase 6, 7, and 8 upon dox stimulation of Saos-2 p73-inducible cell lines (Fig. 1,  C-E) . We found a significant reduction in procaspase 6 steadystate levels (less significant for the other procaspases) 48 h after treatment of Saos-2 p73␤ and p73␥. (Fig. 1, D and E) .
Consistent with the p73␤-and ␥-triggered processing of procaspase 6 and, to a lesser extent, procaspase 8, both isoforms induced apoptosis (Fig. 1F ) after 48 h of dox stimulation. Therefore, expression of p73, in particular the isoforms ␤ and ␥, induces cell death and caspase activation in Saos-2 cells.
p73-induced bax Expression Does Not Correlate with Apoptotic Kinetics-To investigate the possible involvement of Bax in p73-induced apoptosis, we performed a transactivating assay using a reporter plasmid (bax-Pr/Luc) containing the fulllength bax-promoter placed upstream of a luciferase cDNA. We transfected Saos-2 cells expressing the dox-inducible p73␣, ␤, and ␥ isoforms or p53 as a positive control, and the luciferase assay was performed after 24 h. As shown in Fig. 2A , all three p73 isoforms transactivated the bax promoter, although to a lesser degree than p53, with the p73␥ isoform being the most potent transcriptional activator. This is in keeping with previous literature.
Saos-2 cells inducible for p73␥ and p53 expression were also analyzed for Bax protein levels following stimulation with dox by flow cytometric analysis. Interestingly, Bax up-regulation was induced in a time-dependent manner, reaching a maximum at 96 h (Fig. 2, B and C) , thus indicating that the kinetics of Bax expression did not correlate with the induction of apoptosis (Fig. 1F) . Although there are structural and functional similarities between p73 and p53, p73 is a less efficient transcriptional activator of the bax promoter ( Fig. 2A) and a significantly slower inducer of Bax protein expression (Fig 2, B and C) than p53. Hence, at least in our cellular model, the direct transactivation of the bax promoter by p73 does not seem to be the crucial apoptotic effector mechanism driven by p73.
p73 Indirectly Induces Bax Mitochondrial RelocalizationBax translocation from cytosol to mitochondria is a critical step in p53-mediated apoptosis (29) . Bax contributes to apoptosis by interacting with Bcl-2/Bcl-xL and thus controlling mitochondrial protein export. Using confocal and subcellular fractionation studies, we investigated whether Bax re-localization could mediate p73-induced apoptosis in cells stably expressing a Bax-GFP fusion protein (Bax-GFP). Bax-GFP HeLa cells were cotransfected with p73␥ along with a plasmid encoding a red protein that localizes to the mitochondria (pDsRed1-Mito). Confocal microscopy revealed that Bax-GFP was diffusely distributed throughout the cytosol in the absence of p73 overexpression (Fig. 3A, green fluorescence) . However, Bax-GFP moved to a completely punctate distribution, co-localizing with mitochondria 48 h after p73 up-regulation (Fig. 3B) . To further confirm Bax relocalization into mitochondria in apoptotic cells, we performed a Western blot analysis on the purified mitochondrial fraction from the Saos-2 p73␥ subclone 48 h after dox stimulation. As shown in Fig. 3C , induction of p73 revealed a significant increase in Bax protein levels in the mitochondrial fraction as compared with untreated cells. Identical results were obtained using the Bax-GFP HeLa cells (data not shown).
Evidence for transcription-independent, p53-mediated apoptosis has been accumulating (30, 31) . Because during DNA p73 Induces Apoptosis via Bax Subcellular Redistributiondamage-and hypoxia-stimulated apoptosis a fraction of p53 translocates to mitochondria and directly induces cytochrome c release, we sought to examine whether p73 undergoes similar distribution changes. At the same time, the experiment would elucidate if Bax translocation is directly induced by the p73 protein per se. Interestingly, p73 (Fig. 3, green fluorescence) was clearly restricted to the nuclear compartment and did not re-localize during apoptosis triggered either by p73␥ induction (Fig. 3, D and E) or by cisplatin treatment of Saos-2 cells overexpressing p73␥ (Fig. 3F) . Transient transfection of Saos-2 cells with an expression plasmid encoding HA-p73␥ gave identical results to those obtained with Saos-2 stably transfected with p73␥ (data not shown). Thus, unlike p53, p73 does not translocate to mitochondria in response to death signals. Moreover, Bax translocation to the mitochondria is not caused by a direct p73-Bax interaction.
Finally, we monitored cellular distribution of the endogenous Bax protein in the p73␥-inducible clones 48 h after dox stimulation. Fig. 3G shows that Bax (green fluorescence) was spread throughout the cytosol in control cells. On the contrary, Bax displayed a punctate distribution pattern in p73␥-overexpressing cells similar to that observed in Fig. 3B (Fig. 3H) . Comparable results were obtained in Saos-2 cells transfected with an expression plasmid encoding HA-p73␥ (data not shown). These data indicate that p73 and Bax do not co-localize, even at later stages of p73-induced cell death. To more directly investigate the interaction between Bax and p73, we overexpressed both proteins in Saos-2 cells. As shown in Fig. 3I , we did not observe any co-localization of p73 (green fluorescence) in mitochondria (red fluorescence). These results indicate that p73 induces the mitochondrial translocation of Bax through indirect mechanisms. 
PUMA Is Induced by p73 and Causes a Conformational Change and Mitochondrial Translocation of Bax-To
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chondrial translocation, we examined the modulation of several BH3-only proteins (data not shown) that bind to Bcl2/Xl via their BH3 domain, thereby inactivating their protective functions (27, 32) . The recently identified PUMA gene encodes two BH3 domain-containing proteins, PUMA␣ and PUMA␤, that are induced following p53 activation and play a role in mediating p53-induced cell death through the cytochrome c/Apaf-1-dependent pathway (27) . We therefore investigated the possibility that p73 could directly transactivate PUMA. As shown in Fig. 4A , PUMA was transcriptionally induced by p73 within 12 h. The specific roles of the individual PUMA isoforms are not clear at the moment.
We then examined whether PUMA affects Bax translocation to mitochondria during p73-induced apoptosis. As shown in Fig. 4 , B-D, overexpression of both PUMA isoforms in HeLa cells stably transfected with Bax-GFP led to Bax movement from the cytosol to mitochondria 24 h after transfection. In addition, we found that PUMA caused the release of cytochrome c from mitochondria as visualized in HeLa cells stably transfected with cytochrome c-GFP (Fig. 4, E-G) . Therefore, PUMA seems to mediate the effect of p73 on Bax, causing mitochondrial release of cytochrome c to activate the final steps of death in the apoptosome.
To investigate how PUMA physiologically regulates Bax cellular distribution during apoptosis, we took advantage of the 6A7 anti-Bax antibody, which recognizes the activated membrane-bound form of Bax (33) . As shown in Fig. 5A , overexpression of PUMA in U2OS cells led to translocation of the endogenous Bax protein to mitochondria. Interestingly, the active membrane-bound conformation of Bax co-localized with PUMA (Fig. 5A) . Identical results were obtained in a Tet-On, PUMAinducible H1299-derived cell line. Induction of PUMA by dox stimulation resulted in Bax conformational modification and co-localization with PUMA on the mitochondria (Fig. 5B) . The data suggest that PUMA causes a conformational modification of Bax, which then results in its accumulation on the mitochondria.
PUMA-induced Apoptosis Requires Functional Bax/Bak-To formally prove that PUMA-induced cytochrome c release and cell death indeed relies on Bax during p73-mediated apoptosis, we first cotransfected bax Ϫ/Ϫ MEFs with p73␥ and cytochrome c-GFP. We found that p73-induced cytochrome c release was delayed, but not abrogated, in the absence of bax (Fig. 6A , and data not shown). When cells were exposed to DNA damage (25 M cisplatin), apoptosis was indeed slower in bax Ϫ/Ϫ , even though the same plateau was reached (Fig. 6B) . In this experiment, both in bax ϩ/ϩ and bax Ϫ/Ϫ cells, p73 steady-state protein levels were induced within 12 h (Fig. 6C) . This suggests that, indeed, p73 is physiologically induced upon DNA damage and that Bax is not an absolute requirement for inducing apoptosis.
We then measured the ability of PUMA to induce cell death in MEFs of different genotypes. We indeed took advantage of either bax and bak single knock-out cells or bax/bak double deficient cells, which are defective in apoptosis initiated by several other BH3-only proteins (34, 35) . The overexpression of PUMA in wild type fibroblasts caused a significant induction of cell death, which was similar in both bax and bak single null MEFs (Fig. 6B) . Interestingly, bax/bak double null MEFs were completely protected against PUMA-induced apoptosis (Fig.  6D) , thus demonstrating that either Bax or Bak are essential for PUMA to induce cell death. A, U2OS cells were transfected with PUMA␣ for 24 h, and endogenous Bax protein levels were detected by the anti-Bax antibody clone 6A7, which recognizes the activated membrane-bound form of Bax. B, H1299 PUMA␣-inducible cells were transiently transfected with Bax-GFP, stimulated with 2.5 g/ml dox for 8 h before harvesting, and then subjected to immunofluorescence analysis. DAPI, 4Ј,6-diamidino-2-phenylindole.
⌬Np73 Inhibits p73-induced Expression of PUMA, and bax and Reduces Apoptosis-We next sought to test the effect of the ⌬84p73␤ dominant negative mutant, which lacks transcriptional function (24, 36) , on both p73␣ and p53 transcriptional activity. To this end, we cotransfected murine N1E115 neuroblastoma cells with bax-Pr/Luc along with expression plasmids encoding p73␣, ␤, ␥, ␦, or p53 with or without ⌬84p73␤. The results show that ⌬84p73␤ strongly inhibited both p73-and p53-dependent transactivation of the bax-Pr/Luc (Fig. 7A) .
⌬Np73 is a naturally occurring isoform of p73 lacking most of the amino-terminal transactivation domain (24) . The expression of this isoform is regulated by a distinct promoter located in the third intron (24) . This amino-deleted isoform of p73 is highly expressed in tumors, where it seems to play an important role in tumorigenesis (36 -37) . To investigate the role of the ⌬Np73 isoforms, we cotransfected Saos-2 cells with bax-Pr/ Luc, expression plasmids encoding p73␣ or p53 with or without ⌬Np73 isoforms (␣, ␤, and ␥). As shown in Fig. 7B, ⌬Np73 did not have transcriptional activity but efficiently inhibited p73-and p53-dependent transactivation of bax-Pr/Luc. In agreement with these results, we found that TAp73-induced PUMA expression in the p73␥-inducible Saos-2 cell line was completely abrogated in cells stably transfected with ⌬Np73␣ and ⌬Np73␥ (Fig. 7C, lanes 4 -6) .
We also investigated the effect of ⌬Np73␣ on cell death induced by p73 and p53 overexpression (Fig. 7D) . To this aim, we cotransfected Saos-2 cells with expression plasmids encoding p73␣, p73␥, or p53 with or without ⌬Np73␣. Cells were harvested after 72 h. As shown in Fig. 7D , ⌬Np73␣ efficiently abrogated p73-and p53-induced apoptosis.
Conclusions-Although overexpression of p73 leads to activation of reporter genes containing a p53-responsive sequence, growth arrest, and apoptosis, its physiological significance is still unclear. Recent studies indicate that the differential expression of p73 isoforms, together with the interaction between p73 isoforms themselves and with p53, might be crucial in controlling p53 function and programmed cell death (2) (3) 36) .
In the present study, we examined the induction of apoptosis by different p73 isoforms (␣, ␤, and ␥), which occurred 48 h after p73 up-regulation. In our system, the ␥ isoform was the most effective in inducing cell death. We also found that, similarly to p53, all of the p73 isoforms were able to transactivate the bax promoter and induce the expression of the protein in a time-dependent manner. However, transactivation of the bax promoter by p73␥ or p53 was observed only after 72-96 h, much later than p73-and p53-mediated induction of apoptosis. Therefore, p73-induced cell death cannot rely only on the ability of p73 to up-regulate bax expression.
To explain this disparity, we examined the sub-cellular distribution of p73 and Bax during cell death induction. We found that p73 remained in the nucleus during the execution of apoptosis, whereas Bax assumed a punctate distribution pattern co-localizing with mitochondria. Thus, unlike p53 (30, 31), p73 does not display a mitochondrial, transcription-independent, apoptotic function in response to DNA damage. In addition, because p73 and Bax are distributed in different sub-cellular compartments upon cell death induction, any interaction between the two proteins must be indirect. Because this function is normally performed by BH3-only proteins, we searched for their modulation in our model and found that PUMA was the only BH3-only protein significantly modulated by p73 (data not shown). The p53 responsive gene PUMA interacts with Bcl-2, as demonstrated by yeast 2-hybrid screening (27, 28) . Moreover, overexpression of PUMA results in mitochondrial translocation of activated endogenous Bax, which partially co-localizes with PUMA, and cytochrome c release, with similar or even more rapid kinetics than those of p73 on apoptosis. Similarly to other BH3-only proteins, such as Bid, Bim, and Bad, p73 Induces Apoptosis via Bax Subcellular Redistributionwhich bind pro-survival Bcl-2 family members (34, 35) , PUMA requires functional Bax and/or Bak to initiate apoptosis. Therefore, PUMA is an intermediate effector of p73-induced Bax translocation to mitochondria, cytochrome c release, and apoptosis (Fig. 8) .
p73 is expressed in at least six alternatively spliced forms, from ␣ to (1, 26) . Importantly, one spliced variant of p73 (p73⌬exon2), which lacks most of the amino-terminal transactivation domain, has been identified in cancer (1) but not in normal cells. This isoform inhibits p73-induced apoptosis and competes with p53 for DNA binding. This differential expression of p73 isoforms suggests that interaction between p73 isoforms and with p53 may not only modulate p53 function but also have profound effects in the control of programmed cell death (for review, see Ref. 36) .
Recently, new p73 isoforms lacking the whole transactivation domain, called ⌬Np73, were cloned in our laboratory (24) as well as by other groups (38 -42) and were shown to inhibit the apoptotic function of p53 and TAp73 (24) (reviewed in Ref. 36) . Although ⌬Np73 isoforms have no transcriptional activity, they inhibit TAp73-or p53-dependent bax transactivation. On the basis of these results, we also examined the effect of ⌬Np73 isoforms on cell death induced by the TAp73 isoforms or by p53.
Intriguingly, ⌬Np73 isoforms did not induce apoptosis but completely abrogated TAp73-induced cell death and efficiently inhibited p53-induced cell death. Although the data reported here would exclude a major role for bax transactivation in p73-induced apoptosis, the negative effects of ⌬Np73 isoforms on p53-mediated bax-transcription may be regarded as a model for ⌬Np73-mediated suppression of p53/TAp73 transactivation in general. Importantly, we found that ⌬Np73 also inhibited FIG. 8 . p73 induces apoptosis via PUMA-mediated Bax mitochondrial translocation. A schematic representation of the p73 downstream mediators of cell death is shown. p73 transcriptionally regulates both Bax and PUMA. Although Bax induction is not sufficient to trigger apoptosis, PUMA causes mitochondrial relocalization of Bax, thus triggering mitochondrial cytochrome c release and, in turn, leading to apoptotic cell death. The ⌬Np73 protein (and, similarly, other cancer-specific isoforms with deletion of the transactivating domain), regulated by a distinct promoter, inhibits TAp73 and p53 transcriptional properties, hence having anti-apoptotic effects.
FIG. 7. p73⌬N isoforms interfere with TAp73 transcriptional and apoptotic activities.
A, mouse neuroblastoma N1E-115 cells were transiently cotransfected with bax-Pr/Luc and p73␣, p73␤, p73␥, p73␦, or p53 expression vectors in the absence or in the presence of a plasmid encoding ⌬84p73␤. B, Saos-2 cells were transiently cotransfected with bax-Pr/Luc, p73␣, or p53 expression vectors with or without expression plasmids encoding ⌬Np73␣, ⌬Np73␤, or ⌬Np73␥. Cell extracts were prepared 48 h later, and luciferase activity was determined. Results shown in panels A and B are means Ϯ S.D. of three different experiments, each performed in duplicate. C, ⌬Np73 inhibits TAp73-dependent transactivation of PUMA. p73␥-inducible Saos-2 cells were transfected with pcDNA ( lanes 1 and 4), ⌬Np73␣ (lanes 2 and 5) , or ⌬Np73␥ (lanes 3 and 6) together with pBABEpuro. Cells were selected in 1 g/ml puromycin for approximately 2 weeks to obtain stable transfectants. Stable cell lines were then treated with dox (2 g/ml) for 24 h to induce the expression of p73␥ (lanes 4 -6). Total RNA was isolated and subsequently subjected to reverse transcription PCR using PUMA-specific primers. The presence of the ⌬N isoforms of both p73␣ and ␥ abrogated the induction of all PUMA transcripts upon dox treatment (lanes 5 and 6) . The panel shows a representative result of three different experiments performed with identical results. GAPDH, glyceraldehyde-3-phosphate dehydrogenase. D, Saos-2 cells were transiently cotransfected with p73␣, p73␥, or p53 expression vectors with or without expression plasmids encoding ⌬Np73␣. PI staining was performed on cells fixed 72 h later, and apoptosis (expressed as percentage of sub-G 1 hypodiploid events) was assessed. Histograms show the mean Ϯ S.D. of three different experiments, each performed in triplicate.
p73 Induces Apoptosis via Bax Subcellular Redistribution
TAp73-induced PUMA up-regulation, in turn blocking Bax translocation to mitochondria and subsequent cytochrome c release.
Together, these data indicate that the regulation of cell death by p73 occurs via the mitochondrial pathway and is both indirect and complex. The ability of p73 to induce apoptosis is determined by the relative levels of expression of its TAp73 and dominant negative ⌬Np73 isoforms. Where TAp73 isoform expression is dominant, the induction of apoptosis appears to be mediated through the transcriptional activation of PUMA, which facilitates mitochondrial translocation of Bax, rather than by direct transcription of Bax itself. The interactions between the p53 family members now seem much more complex than previously expected (43, 44) , resulting in a very tight regulation of the death pathways. The emergence of increasing complexity in cell death pathways enhances options for the manipulation of altered death/survival pathways in pathological conditions.
